Combination therapy of statin and ezetimibe for the treatment of familial hypercholesterolemia
Open Access
- 1 November 2010
- journal article
- review article
- Published by Taylor & Francis in Vascular Health and Risk Management
- Vol. 6, 1023-37
- https://doi.org/10.2147/vhrm.s13496
Abstract
Peer reviewed article authored by (Ian Hamilton-Craig, Karam Kostner, David Colquhoun, et al). Read article or submit your manuscript for publishing.Keywords
This publication has 83 references indexed in Scilit:
- Indices of Cholesterol Metabolism and Relative Responsiveness to Ezetimibe and SimvastatinJournal of Clinical Endocrinology & Metabolism, 2010
- Ezetimibe reduces plaque inflammation in a rabbit model of atherosclerosis and inhibits monocyte migration in addition to its lipid‐lowering effectBritish Journal of Pharmacology, 2009
- Impact of Ezetimibe on Atherosclerosis: Is the Jury Still Out?Mayo Clinic Proceedings, 2009
- Evidence for Statin Pleiotropy in HumansCirculation, 2009
- Effect of Statins Alone Versus Statins Plus Ezetimibe on Carotid Atherosclerosis in Type 2 DiabetesJournal of the American College of Cardiology, 2008
- Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive ProteinNew England Journal of Medicine, 2008
- Child-parent screening for familial hypercholesterolaemia: screening strategy based on a meta-analysisBMJ, 2007
- Achieving lipoprotein goals in patients at high risk with severe hypercholesterolemia: Efficacy and safety of ezetimibe co-administered with atorvastatinAmerican Heart Journal, 2004
- Effectiveness and tolerability of ezetimibe add-on therapy to a bile acid resin-based regimen for hypercholesterolemiaThe American Journal of Cardiology, 2004
- Documented need for more effective diagnosis and treatment of familial hypercholesterolemia according to data from 502 heterozygotes in UtahThe American Journal of Cardiology, 1993